Company intelligence / Profile preview
Intas Pharmaceuticals
Ahmedabad city, Gujaratintaspharma.com ↗
- Ownership
- Private
- Employees
- ~23000
- Development stage
- Commercial
01
Overview
Intas Pharmaceuticals operates one of the largest commercialized portfolios of generic drugs and biosimilars in India with significant international presence. It was the first Indian company to launch a biosimilar in Europe. Its biologics division has at least thirteen commercialized products with six more in late-stage pipeline development. The company’s R&D focuses on oncology/cancer therapies as well as autoimmune diseases and other high-value therapeutic areas. Facilities are accredited by major global regulators including USFDA and EMA. Recent acquisitions have expanded its US/EU product portfolio further—e.g., acquisition of UDENYCA from Coherus BioSciences to accelerate its FDA-approved offerings.
- Therapeutic areas
- Men's HealthOncologyEndocrinologyImmunologyOtherNeurologyGastroenterologyCardiovascularOphthalmologyNephrologyInfectious Diseases
- Modalities
- Small moleculesBiosimilars/biologics (including monoclonal antibodies, rDNA products, plasma-derived products)Monoclonal antibodiesNovel drug delivery systems (microspheres, liposomes, inhalation tech)
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Strategic marketing alliances for registration/distribution of biosimilars in over thirty countriesrecent acquisition partnership with Coherus BioSciences regarding UDENYCA product line expansion into US market
Beyond the preview
Go deeper on Intas Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intas Pharmaceuticals.